Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890158717> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2890158717 endingPage "500.e9" @default.
- W2890158717 startingPage "500.e1" @default.
- W2890158717 abstract "Abstract Objective This retrospective observational study assessed if second-line chemotherapy vs. androgen receptor-targeted agents (ARTAs; abiraterone/enzalutamide) is associated with improved outcomes in metastatic castration-resistant prostate cancer (mCRCaP) patients who experience early progression on first-line ARTAs in a US community setting. Methods Patients with mCRCaP (n = 345) who progressed ≤ 12 months after first-line ARTA and received second-line chemotherapy (docetaxel/cabazitaxel; n = 147) or ARTA (n = 198) between May 2011 and October 2014 were identified. Overall survival (OS), prostate-specific antigen (PSA) response and progression, and clinical response were compared for second-line chemotherapy vs. ARTA, using one-sided tests from second-line therapy initiation. Multivariate analyses were adjusted for: year, age, metastases, opioid use, Eastern Cooperative Oncology Group performance score, PSA, hemoglobin, alkaline phosphatase, lactate dehydrogenase (LDH), and albumin levels. Results Patients receiving second-line chemotherapy vs. ARTA were younger (median: 74 vs. 79 years) and had a poorer prognosis in terms of PSA, LDH, alkaline phosphatase, albumin and hemoglobin levels, opioid use, and Halabi risk score (P upper limit of normal: aHR = 0.18, P = 0.014; albumin Conclusion Following early progression on first-line ARTA, second-line chemotherapy may be more beneficial in mCRCaP compared with second-line ARTA in patients with a poor prognosis." @default.
- W2890158717 created "2018-09-27" @default.
- W2890158717 creator A5018292930 @default.
- W2890158717 creator A5035186998 @default.
- W2890158717 creator A5043332548 @default.
- W2890158717 creator A5048218438 @default.
- W2890158717 creator A5048953246 @default.
- W2890158717 creator A5053962996 @default.
- W2890158717 creator A5063896009 @default.
- W2890158717 creator A5089164304 @default.
- W2890158717 date "2018-11-01" @default.
- W2890158717 modified "2023-10-03" @default.
- W2890158717 title "Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting" @default.
- W2890158717 cites W1139515337 @default.
- W2890158717 cites W1996389184 @default.
- W2890158717 cites W2005958584 @default.
- W2890158717 cites W2009337680 @default.
- W2890158717 cites W2055346449 @default.
- W2890158717 cites W2108679313 @default.
- W2890158717 cites W2114282601 @default.
- W2890158717 cites W2118564089 @default.
- W2890158717 cites W2137467802 @default.
- W2890158717 cites W2144439788 @default.
- W2890158717 cites W2156923287 @default.
- W2890158717 cites W2159771669 @default.
- W2890158717 cites W2166305340 @default.
- W2890158717 cites W2166918329 @default.
- W2890158717 cites W2515872486 @default.
- W2890158717 cites W2570618306 @default.
- W2890158717 cites W2659875471 @default.
- W2890158717 cites W2736956815 @default.
- W2890158717 cites W4252724219 @default.
- W2890158717 doi "https://doi.org/10.1016/j.urolonc.2018.08.002" @default.
- W2890158717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30201382" @default.
- W2890158717 hasPublicationYear "2018" @default.
- W2890158717 type Work @default.
- W2890158717 sameAs 2890158717 @default.
- W2890158717 citedByCount "35" @default.
- W2890158717 countsByYear W28901587172019 @default.
- W2890158717 countsByYear W28901587172020 @default.
- W2890158717 countsByYear W28901587172021 @default.
- W2890158717 countsByYear W28901587172022 @default.
- W2890158717 countsByYear W28901587172023 @default.
- W2890158717 crossrefType "journal-article" @default.
- W2890158717 hasAuthorship W2890158717A5018292930 @default.
- W2890158717 hasAuthorship W2890158717A5035186998 @default.
- W2890158717 hasAuthorship W2890158717A5043332548 @default.
- W2890158717 hasAuthorship W2890158717A5048218438 @default.
- W2890158717 hasAuthorship W2890158717A5048953246 @default.
- W2890158717 hasAuthorship W2890158717A5053962996 @default.
- W2890158717 hasAuthorship W2890158717A5063896009 @default.
- W2890158717 hasAuthorship W2890158717A5089164304 @default.
- W2890158717 hasBestOaLocation W28901587171 @default.
- W2890158717 hasConcept C121608353 @default.
- W2890158717 hasConcept C126322002 @default.
- W2890158717 hasConcept C143998085 @default.
- W2890158717 hasConcept C2776694085 @default.
- W2890158717 hasConcept C2780192828 @default.
- W2890158717 hasConcept C61367390 @default.
- W2890158717 hasConcept C71924100 @default.
- W2890158717 hasConceptScore W2890158717C121608353 @default.
- W2890158717 hasConceptScore W2890158717C126322002 @default.
- W2890158717 hasConceptScore W2890158717C143998085 @default.
- W2890158717 hasConceptScore W2890158717C2776694085 @default.
- W2890158717 hasConceptScore W2890158717C2780192828 @default.
- W2890158717 hasConceptScore W2890158717C61367390 @default.
- W2890158717 hasConceptScore W2890158717C71924100 @default.
- W2890158717 hasFunder F4320307781 @default.
- W2890158717 hasIssue "11" @default.
- W2890158717 hasLocation W28901587171 @default.
- W2890158717 hasOpenAccess W2890158717 @default.
- W2890158717 hasPrimaryLocation W28901587171 @default.
- W2890158717 hasRelatedWork W1844925317 @default.
- W2890158717 hasRelatedWork W2140917627 @default.
- W2890158717 hasRelatedWork W2299690226 @default.
- W2890158717 hasRelatedWork W2783882412 @default.
- W2890158717 hasRelatedWork W3014214351 @default.
- W2890158717 hasRelatedWork W3023947295 @default.
- W2890158717 hasRelatedWork W3200282916 @default.
- W2890158717 hasRelatedWork W4229076799 @default.
- W2890158717 hasRelatedWork W4285391746 @default.
- W2890158717 hasRelatedWork W4295836975 @default.
- W2890158717 hasVolume "36" @default.
- W2890158717 isParatext "false" @default.
- W2890158717 isRetracted "false" @default.
- W2890158717 magId "2890158717" @default.
- W2890158717 workType "article" @default.